CA24477V1058
CA24477V1058
Definium Therapeutics, Inc.
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2025 | 2024 | Change % |
|---|---|---|---|
| Total Revenue | -- | -- | -- |
| Cost of Revenue | -- | -- | -- |
| Gross Profit | -- | -- | -- |
| 166.309.000 | 103.916.000 | 60.0% | |
| Operating Income | -166.309.000 | -103.916.000 | 60.0% |
| Pretax Income | -183.793.000 | -108.679.000 | 69.1% |
| Net Income Common Stockholders | -183.793.000 | -108.679.000 | 69.1% |
| -- | -- | -- | |
| -- | -- | -- |